Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-18 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Lippis Daniel J. CIK: 0002004380 Role: Officer (CVP, TAVR) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-18 | Code: M (Exercise of derivative) Shares: +620 | Price: $72.68 Total Value: $45,061.60 Shares Owned After: 41,030.9103 | Ownership: D (Direct) Footnotes: [F1] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026. [Transaction #2] Security: Common Stock Date: 2026-05-18 | Code: S (Open market sale) Shares: -620 | Price: $81.14 Total Value: $50,306.80 Shares Owned After: 40,410.9103 | Ownership: D (Direct) Footnotes: [F1] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026. --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (Right to Acquire) Date: 2026-05-18 | Code: M (Exercise of derivative) Shares: -620 | Price: $0.00 Exercisable: N/A | Expires: 2027-05-06 Shares Owned After: 6,190 | Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-05-18)